paper
base
relev
literatur
articl
author
clinic
experi
present
goalori
respiratori
manag
critic
ill
patient
acut
respiratori
distress
syndrom
ard
help
improv
clinician
abil
care
patient
earli
recognit
ard
modifi
risk
factor
avoid
aggrav
factor
hospit
stay
nonprotect
mechan
ventil
multipl
blood
product
transfus
posit
fluid
balanc
ventilatorassoci
pneumonia
gastric
aspir
help
decreas
incid
earli
extens
clinic
laboratori
imag
evalu
risk
patient
allow
correct
diagnosi
ard
assess
comorbid
calcul
prognost
indic
care
treatment
plan
rapid
administr
antibiot
resuscit
measur
case
sepsi
septic
shock
associ
protect
ventilatori
strategi
earli
shortterm
paralysi
associ
differenti
ventilatori
techniqu
recruit
maneuv
adequ
posit
endexpiratori
pressur
titrat
prone
posit
new
extracorpor
membran
oxygen
techniqu
sever
ard
help
improv
prognosi
revalu
ard
patient
third
day
evolut
sequenti
organ
failur
assess
sofa
biomark
respons
infect
therapi
allow
chang
initi
treatment
plan
help
decreas
ard
mortal
acut
respiratori
distress
syndrom
ard
due
increas
pulmonari
alveolarcapillari
membran
permeabl
caus
lung
edema
rich
protein
consequ
acut
hypoxem
respiratori
failur
genet
suscept
patient
expos
determin
risk
factor
recent
studi
show
deldel
genotyp
patient
homozyg
base
pair
delet
promot
associ
agedepend
increas
odd
develop
ard
ci
patient
deldel
genotyp
ard
also
increas
hazard
mortal
hr
ci
organ
failur
p
age
group
may
affect
although
syndrom
higher
incid
mortal
older
peopl
common
precipit
caus
ard
pulmonari
infect
nonpulmonari
sepsi
shock
gastric
aspir
thorac
trauma
fat
embol
near
drown
inhal
injuri
cardiopulmonari
bypass
drug
overdos
acut
pancreat
highrisk
trauma
especi
traumat
brain
injuri
recent
epidemiolog
studi
suggest
varieti
intrahospit
risk
factor
ard
develop
multipl
blood
product
transfus
mechan
ventil
high
tidal
volum
excess
fluid
resuscit
hospitalacquir
pneumonia
well
highrisk
surgeri
especi
aortic
vascular
cardiac
acut
abdomen
risk
factor
potenti
prevent
chronic
alcohol
abus
chronic
liver
diseas
immunosuppress
hypoalbuminemia
obes
also
associ
develop
ard
wherea
diabet
mellitu
appear
protect
exposur
risk
factor
import
activ
neutrophil
releas
harm
mediat
includ
cytokin
interleukin
solubl
tumor
necrosi
factoralpha
receptor
proteas
reactiv
oxygen
speci
matrix
metalloproteinas
lead
futur
damag
overwhelm
pulmonari
inflammatori
process
initi
lead
alveolar
epitheli
vascular
endotheli
injuri
alveolar
epitheli
injuri
type
cell
contribut
pulmonari
edema
breakdown
epitheli
barrier
expos
underli
basement
membran
predispos
bacteremia
sepsi
injuri
type
ii
alveolar
cell
lead
impair
surfact
function
consequ
collaps
lung
histopatholog
diffus
alveolar
damag
neutrophil
infiltr
alveolar
hemorrhag
hyalin
membran
format
local
destruct
occlus
vascular
bed
lung
intravascular
thrombosi
increment
anatom
dead
space
result
increas
arteri
carbon
dioxid
associ
poor
outcom
fibrosi
evid
histolog
earli
one
week
onset
ard
procollagen
iii
peptid
precursor
collagen
synthesi
elev
bronchoalveolar
lavag
fluid
ard
patient
time
tracheal
intub
increment
associ
poor
ard
prognosi
vascular
injuri
remodel
may
lead
pulmonari
arteri
hypertens
may
compromis
right
ventricular
function
associ
poor
clinic
outcom
incorpor
modifi
risk
factor
acut
increas
respiratori
rate
presenc
tachypnea
detect
puls
oximet
desatur
increas
necess
oxygen
supplement
presenc
low
ph
acidosi
hypoxemia
arteri
blood
ga
sampl
clinic
practic
improv
clinician
abil
perform
earli
diagnosi
prompt
therapeut
intervent
ard
presenc
modifi
risk
factor
may
alert
physician
avoid
secondari
hospit
exposur
blood
product
transfus
excess
fluid
administr
infus
potenti
toxic
drug
high
tidal
volum
mechan
ventil
gastric
aspir
implement
ventil
associ
pneumonia
prevent
bundl
decreas
incid
vap
lower
incid
ard
implement
autom
ard
electron
screen
usa
hospit
assist
electron
alert
laboratori
arteri
blood
ga
analysi
show
hypoxemia
radiolog
depart
chest
xray
show
bilater
pulmonari
infiltr
identifi
intub
patient
ard
medic
surgic
icu
show
sensit
ci
specif
ci
compar
manual
screen
algorithm
sensit
ci
specif
ci
icu
patient
period
enrol
ardsnet
trial
result
studi
indic
advantag
inhospit
autom
screen
ard
manual
screen
autom
screen
increas
chanc
ard
diagnosi
alert
clinician
elicit
rapid
respons
hospit
team
intensivist
initi
clinic
protocol
ard
therapeut
intervent
hospit
intens
care
unit
worldwid
use
standard
criteria
diagnosi
acut
lung
injuri
ali
ard
presenc
acut
hypoxemia
pao
fio
less
mmhg
kpa
ali
less
mmhg
kpa
ard
bilater
infiltr
seen
frontal
chest
radiograph
consist
pulmonari
edema
clinic
evid
left
atrial
hypertens
measur
pulmonari
arteri
wedg
pressur
pawp
less
mmhg
accord
americaneuropean
consensu
confer
ard
aecc
definit
aim
simplifi
standard
diagnosi
ard
worldwid
howev
clinic
practic
order
detect
diagnos
aliard
case
physician
must
focu
patient
complaint
physic
examin
alter
patient
risk
develop
diseas
patient
present
finger
puls
oximet
desatur
follow
aliard
clinic
suspicion
physician
order
arteri
blood
ga
analysi
chest
radiograph
abl
confirm
aliard
diagnosi
recent
updat
ard
definit
delphi
consensu
berlin
definit
publish
order
improv
ard
diagnosi
criteria
berlin
definit
reclassifi
ard
mild
pao
fio
kpa
moder
pao
fio
kpa
sever
pao
fio
mmhg
kpa
remov
term
ali
necess
swan
ganz
cathet
access
pawp
acut
time
frame
specifi
onset
within
week
known
clinic
insult
new
worsen
respiratori
symptom
chest
radiographi
criteria
clarifi
bilater
opac
consist
pulmonari
edema
maintain
main
radiolog
criteria
ard
recogn
find
could
demonstr
ct
scan
instead
chest
radiograph
recent
berlin
definit
ard
decis
step
forward
refin
diagnosi
syndrom
pao
fio
influenc
ventil
set
fact
consid
bilater
pulmonari
infiltr
result
wide
varieti
acut
lung
diseas
better
investig
left
right
ventricular
function
pulmonari
arteri
pressur
volem
statu
could
better
evalu
bedsid
echocardiographi
extravascular
lung
water
measur
use
picco
cathet
order
evalu
degre
pulmonari
edema
predictor
mortal
calcul
icu
admiss
inform
icu
team
program
care
treatment
plan
accord
diseas
sever
berlin
definit
show
better
predict
valid
mortal
compar
aecc
definit
absolut
valu
area
receiv
oper
curv
still
small
suggest
factor
still
miss
discuss
research
need
reach
comprehens
definit
ard
critic
care
research
practic
typic
find
ard
comput
tomographi
reveal
heterogen
bilater
pulmonari
infiltr
predominantli
gravitydepend
region
lung
preserv
lung
nondepend
lung
region
use
quantit
analysi
ct
scan
gravitydepend
pulmonari
ard
infiltr
typic
nonaer
lung
tissu
consist
compress
atelectasi
lung
weight
assess
ct
scan
increas
ard
correl
sever
syndrom
find
concomit
interstiti
infiltr
suggest
viral
mycoplasma
chlamydia
opportunist
pulmonari
infect
druginduc
lung
diseas
differenti
diagnosi
bilater
pneumonia
alveolar
hemorrhag
acut
interstiti
lung
diseas
acut
interstiti
pneumonia
hypersensit
pneumon
acut
eosinophil
pneumonia
bronchiol
obliteran
organ
pneumonia
suggest
characterist
ct
scan
find
specif
diseas
result
stepwis
lung
recruit
maneuv
well
posit
endexpiratori
peep
titrat
keep
lung
open
minim
collaps
assess
comput
tomographi
analysi
strategi
aim
open
lung
keep
lung
open
quickli
earli
possibl
postul
lachmann
order
huge
improv
lung
function
avoid
potenti
ventilatorinduc
lung
injuri
recent
group
report
experi
maxim
recruit
strategi
mr
patient
ard
mr
consist
step
tidal
ventil
pressurecontrol
ventil
fix
drive
pressur
cmh
respiratori
rate
breathsminut
inspiratoryexpiratori
ratio
stepwis
increment
peep
level
cmh
recruit
phase
peep
decreas
cmh
cmh
peep
titrat
phase
step
cmh
one
last
minut
step
comput
tomographi
imag
sequenc
carina
diaphragm
acquir
expiratori
paus
second
lung
collaps
assess
onlin
visual
inspect
immedi
clinic
decis
offlin
quantit
measur
mr
show
statist
signific
decreas
nonaer
area
ard
lung
accompani
signific
increment
oxygen
open
plateau
pressur
observ
recruit
protocol
cmh
mean
peep
titrat
mr
cmh
mean
pao
fio
ratio
increas
p
mr
sustain
throughout
seven
day
nonaer
parenchyma
decreas
significantli
interquartil
rang
iqr
iqr
p
mr
potenti
recruit
lung
estim
iqr
figur
icu
mortal
hospit
mortal
independ
risk
factor
associ
mortal
older
age
higher
drive
pressur
higher
delta
pressur
control
signific
clinic
complic
mr
barotrauma
better
evolut
ard
patient
less
necess
oxygen
supplement
recoveri
phase
diseas
better
qualiti
life
must
test
prospect
control
clinic
trial
recent
metaanalysi
show
benefici
effect
mortal
use
higher
peep
level
compar
lower
peep
ard
patient
corrobor
result
clinic
case
seri
ard
patient
submit
mr
ard
biphas
diseas
progress
acut
exud
phase
character
epitheli
endotheli
injuri
neutrophil
aggreg
format
hyalin
membran
alveolar
edema
hemorrhag
organ
phase
character
regener
heal
via
resolut
repair
persist
intraalveolar
interstiti
fibrosi
crucial
make
diagnosi
ard
acut
phase
prefer
less
hour
order
make
possibl
open
lung
recruit
maneuv
keep
lung
open
suffici
peep
level
enabl
homogen
ventil
minim
possibl
ventilatorinduc
lung
injuri
vili
trigger
allow
recoveri
lung
recent
studi
analyz
patient
ard
grade
six
find
accord
extent
fibroprolifer
ct
scan
show
higher
ct
score
associ
statist
signific
decreas
organfailur
free
day
well
ventil
free
day
independ
risk
factor
mortal
ci
p
positron
emiss
tomographi
f
fluorodeoxyglucos
fdgpet
detect
inflammatori
cell
assess
lung
inflamm
ard
lung
help
understand
ard
physiopatholog
lung
ultrasonographi
new
help
tool
perform
bedsid
without
radiat
exposur
thorac
ultrasound
wide
use
diagnost
therapeut
intervent
patient
pleural
effus
pneumothorac
assess
lung
recruit
peep
titrat
ard
patient
bedsid
use
lung
ultrasonographi
new
promis
techniqu
current
two
main
limit
techniqu
inabl
detect
lung
overdistens
operatordepend
characterist
thorac
electr
imped
tomographi
eit
highli
promis
imag
techniqu
appli
bedsid
peep
titrat
ard
patient
new
autom
tool
permit
calcul
percentag
collaps
well
overdistend
lung
tissu
decrement
peep
level
lung
recruit
maneuv
figur
region
distribut
collaps
overdistens
may
provid
insight
lung
patholog
techniqu
permit
daili
peep
adjust
bedsid
verif
tidal
volum
distribut
avoid
excess
endexpiratori
collaps
tidal
overdistent
one
main
sofa
score
first
day
mr
p
advantag
techniqu
possibl
around
clock
monitor
studi
need
evalu
clinic
impact
bedsid
techniqu
ard
patient
prognosi
random
trial
suggest
patient
acut
hypoxem
respiratori
failur
less
like
requir
endotrach
intub
noninvas
ventil
niv
ad
standard
therapi
howev
studi
analyz
mix
caus
acut
hypoxem
respiratori
failur
report
highest
intub
rate
patient
ard
presenc
ard
one
factor
independ
associ
niv
failur
higher
mortal
rate
recent
zhan
colleagu
analyz
patient
ard
randomli
alloc
receiv
either
noninvas
ventil
highconcentr
oxygen
therapi
venturi
mask
noninvas
posit
pressur
ventil
decreas
respiratori
rate
improv
pao
fio
time
proport
patient
requir
intub
invas
mechan
ventil
significantli
lower
noninvas
ventil
group
one
versu
p
therefor
noninvas
ventil
use
first
ventilatori
support
techniqu
select
patient
mildmoder
ard
hemodynam
stabl
condit
avoid
endotrach
intub
larger
random
trial
howev
requir
need
intub
mortal
outcom
interest
closemonitor
initi
trial
noninvas
ventil
consid
mildmoder
ard
patient
mainli
immunosuppress
one
pulmonari
infect
order
avoid
intub
invas
mechan
ventil
howev
earli
detect
collaps
promin
right
lung
analyz
sequenc
eit
imag
peep
select
patient
cmh
believ
repres
best
compromis
collaps
overdistens
accord
ardsnet
peepfio
tabl
patient
ventil
peep
cmh
previou
hour
patient
wean
ventil
day
later
niv
failur
must
recogn
prompt
intub
mechan
ventil
must
provid
order
avoid
complic
protect
ard
mechan
ventil
strategi
tidal
volum
equal
less
mlkg
predict
bodi
weight
tradit
associ
reduc
mortal
compar
mlkg
predict
bodi
weight
recent
metaanalysi
howev
scrutin
specif
role
variou
ventilatori
strategi
use
random
trial
lung
protect
like
plateaupressur
limit
higher
peep
use
show
tidal
volum
per
se
exactli
import
paramet
priorit
demonstr
decreas
lung
inflamm
protect
ventilatori
strategi
although
result
encourag
physiolog
background
support
use
pv
curv
titrat
peep
lack
consist
nowaday
mani
differ
situat
investig
report
larg
dissoci
close
pressur
lung
calcul
valu
inflect
point
obtain
inspiratori
pv
curv
gener
patient
high
valu
inflect
point
tend
sever
diseas
may
explain
rel
success
strategi
nevertheless
probabl
use
better
tool
titrat
peep
next
year
consist
use
pv
curv
demonstr
analysi
lung
recruit
airway
pressur
releas
ventil
modifi
form
continu
posit
airway
ventil
cpap
describ
stock
dow
use
fairli
high
prolong
cpap
level
short
intermitt
releas
airway
pressur
low
cpap
level
allow
ventil
co
clearanc
mode
ventilatori
support
enhanc
oxygen
augment
alveolar
recruit
requir
less
sedat
use
ard
patient
compar
convent
mechan
ventil
bipap
ventil
combin
lung
recruit
maneuv
also
use
ard
patient
wang
colleagu
compar
modal
ventilatori
support
assistcontrol
volum
ventil
prospect
random
trial
ard
patient
show
better
pao
fio
ratio
pulmonari
complianc
shorter
durat
mechan
ventil
pressur
support
ventil
psv
along
suffici
peep
level
use
earli
possibl
ard
patient
avoid
respiratori
muscl
dystrophi
decreas
mechan
ventil
durat
reason
improv
oxygen
obtain
psv
ard
challeng
recent
year
appar
improv
recruit
seem
overst
evid
relat
increas
perfus
better
ventil
lung
area
decreas
lung
collaps
grow
concern
relat
excess
tidal
recruit
excess
dyssynchroni
mode
ventil
better
address
next
year
advantag
use
assist
mode
keep
respiratori
muscl
activ
sometim
difficult
synchron
patient
ventil
recent
neural
adjust
ventil
nava
use
ard
experiment
model
ard
patient
demonstr
ventil
cycl
magnitud
assist
breath
nava
match
patient
breath
pattern
better
psv
nava
improv
patientventil
synchroni
compar
psv
high
frequenc
oscillatori
ventil
hfov
altern
mode
ventilatori
support
improv
oxygen
mean
higher
mean
airway
pressur
coupl
small
tidal
volum
gener
piston
pump
oscil
frequenc
hz
higher
respiratori
rate
howev
date
studi
involv
small
number
patient
compar
hfov
convent
ventil
recent
metaanalysi
suggest
trend
toward
mortal
benefit
ventil
free
day
howev
result
analysi
interpret
cautious
main
studi
contribut
result
use
high
tidal
volum
control
group
rather
protect
lung
ventil
strategi
use
posit
chang
supin
prone
lead
consist
improv
arteri
oxygen
ard
patient
larg
random
control
trial
consist
show
improv
oxygen
without
reduct
durat
mechan
ventil
surviv
benefit
recent
metaanalys
suggest
surviv
benefit
ard
patient
specif
subgroup
patient
sever
ard
pao
fio
mmhg
experi
prone
posit
accept
altern
improv
oxygen
sever
ard
patient
arteri
pulmonari
hypertens
right
ventricular
dysfunct
associ
use
inhal
nitric
oxid
minim
intrathorac
pressur
facilit
right
ventricular
perform
principl
protect
ventil
proper
peep
titrat
minimum
drive
pressur
also
pursu
prone
posit
protocol
clinic
studi
suggest
elev
pulmonari
arteri
systol
pressur
ard
patient
associ
advers
prognosi
data
support
recent
analysi
hemodynam
data
ardsnet
fluid
cathet
therapi
trial
factt
investig
assess
transpulmonari
gradient
tpg
mean
pa
pressurepulmonari
capillari
occlus
pressur
pcop
pulmonari
vascular
resist
index
pvri
group
patient
random
receiv
pulmonari
arteri
cathet
guid
ard
manag
note
patient
receiv
consist
protect
ventil
strategi
target
tidal
volum
mlkg
ideal
bodi
weight
plateau
pressur
maintain
cmh
highest
record
daili
valu
tpg
pvri
use
analysi
popul
patient
random
receiv
pulmonari
arteri
cathet
ard
manag
none
baselin
measur
cardiopulmonari
dysfunct
includ
central
venou
pressur
pa
systol
diastol
pressur
pulmonari
capillari
occlus
pressur
paop
cardiac
index
distinguish
survivor
nonsurvivor
pulmonari
arteri
cathet
popul
demonstr
elev
transpulmonari
gradient
tpg
patient
tpg
mmhg
significantli
greater
mortal
rate
patient
tpg
mmhg
versu
p
patient
persist
elev
tpg
day
therapi
significantli
greater
mortal
patient
elev
tpg
day
subsequ
normal
multivari
analysi
pulmonari
vascular
dysfunct
repres
elev
tpg
pvri
remain
independ
predictor
advers
outcom
ard
popul
data
support
import
predict
role
pulmonari
vascular
diseas
ard
outcom
largest
publish
echocardiograph
seri
ard
patient
receiv
consist
lung
protect
ventil
strategi
mean
peep
cmh
mean
plateau
pressur
pplat
cmh
evid
acut
cor
pulmonal
popul
demonstr
evid
moderatetolarg
patent
foramen
oval
incid
right
left
shunt
increas
patient
echocardiograph
evid
acut
cor
pulmonal
increas
oxygen
co
remov
make
ard
patient
blood
pass
throughout
membran
oxygen
outsid
bodi
principl
extracorpor
membran
oxygen
appli
venousven
good
oxygen
co
remov
arterialven
good
co
remov
venousarteri
good
cardiovascular
support
earli
clinic
trial
ecmo
employ
primarili
arterialven
strategi
larger
bore
cathet
patient
intract
hypoxemia
modern
investig
use
safer
venousven
access
approach
recent
uk
prospect
random
clinic
trial
cesar
show
surviv
advantag
ecmo
group
ecmo
versu
control
nevertheless
studi
critic
standard
protocol
manag
control
group
patient
ecmo
arm
receiv
propos
treatment
author
cesar
trial
also
recommend
transfer
adult
patient
sever
potenti
revers
respiratori
failur
ph
less
optim
convent
manag
center
ecmobas
manag
protocol
significantli
improv
surviv
without
sever
disabl
author
demonstr
strategi
also
like
cost
effect
set
similar
servic
unit
kingdom
anoth
recent
approach
applic
extracorpor
carbon
dioxid
remov
new
devic
ecmor
ard
patient
demonstr
sever
ard
even
low
tidal
volum
ventil
mlkg
predict
bodi
weight
caus
tidal
hyperdistens
nondepend
region
lung
accompani
plateau
airway
pressur
greater
cmh
elev
plasma
marker
inflamm
group
applic
ecmor
could
allow
author
decreas
tidal
volum
less
mlkg
consequ
plateau
pressur
less
cmh
associ
lower
radiograph
index
lung
injuri
lower
level
lungderiv
inflammatori
cytokin
howev
prognost
implic
new
ecmor
devic
applic
clinic
practic
still
investig
pumpless
intervent
lung
assist
ila
also
use
patient
ard
aim
improv
extracorpor
ga
exchang
membran
integr
passiv
arterioven
shunt
ila
serv
extracorpor
assist
support
mechan
ventil
enabl
low
tidal
volum
reduc
inspiratori
plateau
pressur
extrem
sever
ard
patient
zimmermann
colleagu
use
ila
sever
ard
patient
observ
decreas
paco
allow
decreas
tidal
volum
plateau
pressur
ultraprotect
ventil
hospit
mortal
rate
author
suggest
use
combin
ventilatori
strategi
patient
ard
bingold
colleagu
success
use
superimpos
highfrequ
jet
ventil
shfjv
combin
continu
posit
airway
pressureassist
spontan
breath
cpapasb
five
patient
ard
improv
oxygen
varpula
colleagu
demonstr
signific
improv
oxygen
ard
patient
compar
apvr
associ
prone
ventil
simvpressur
controlpressur
support
group
aprv
h
appear
enhanc
improv
oxygen
respons
prone
posit
rival
colleagu
examin
effect
prone
posit
associ
recruit
maneuv
consist
cmh
extend
sigh
pressur
control
ard
patient
combin
ventilatori
techniqu
led
highest
increas
pao
fio
ratio
without
signific
clinic
side
effect
lubnow
colleagu
examin
effect
day
combin
highfrequ
oscillatori
ventil
hfov
extracorpor
carbon
dioxid
remov
intervent
lung
assist
ila
sever
ard
patient
fail
convent
ventil
observ
increas
pao
fio
ratio
ph
decreas
paco
wean
hfovila
success
patient
mortal
rate
hospit
mortal
rate
conclus
combin
ventilatori
strategi
appli
sever
ard
patient
best
match
among
avail
ventilatori
techniqu
still
matter
debat
pulmonari
infect
sepsi
import
trigger
factor
ard
pulmonari
infect
associ
higher
risk
ard
progress
comparison
nonpulmonari
infect
risk
popul
wide
varieti
organ
invad
respiratori
tract
trigger
host
innat
acquir
immun
system
initi
inflammatori
cascad
ard
sepsi
multipl
organ
failur
particularli
pertin
investig
etiolog
pulmonari
infect
first
day
assess
nasal
swab
respiratori
viru
detect
influenza
adenoviru
lower
respiratori
tract
secret
bronchoalveolar
lavag
fluid
balf
bacteria
especi
multiresist
speci
virus
herp
cytomegaloviru
coronaviru
metapneumon
viru
opportunist
agent
pneumocysti
jiroveci
must
investig
immunosuppress
patient
urinari
screen
legionella
speci
decis
posit
specif
therapi
must
introduc
assess
balf
first
well
third
day
mechan
ventil
utmost
import
term
assess
etiolog
pulmonari
infect
also
assess
proinflammatori
mediat
ard
il
solubl
tumor
necrosi
factoralpha
receptor
stnfr
solubl
intercellular
adhes
mediat
ventilatorinduc
lung
injuri
also
obtain
plasma
stnfr
indic
epitheli
cell
injuri
solubl
advanc
glycat
endproduct
receptorssrag
surfact
proteind
compon
coagul
system
proteinc
plasminogen
activ
inhibitor
elev
level
procollagen
peptid
iii
lavag
fluid
patient
day
ard
independ
risk
factor
mortal
procalcitonin
pct
creactiv
protein
crp
progress
use
critic
care
set
order
diagnos
pulmonari
infect
sepsi
guid
antibiot
therapi
procalcitonin
level
correl
sever
sepsi
bacteraemia
pctbase
algorithm
guid
initi
durat
antibiot
therapi
critic
ill
patient
suspect
bacteri
infect
associ
rel
reduct
antibiot
exposur
signific
increas
mortal
persist
elev
serum
crp
critic
ill
patient
ard
may
alert
intensivist
possibl
persist
infect
inflammatori
process
moment
new
workup
infect
chang
antibiot
therapi
could
help
improv
patient
evolut
earli
quick
administr
antibiot
sepsi
septic
shock
well
earli
goal
resuscit
measur
septic
shock
earli
goaldirect
therapi
decreas
mortal
high
mortal
critic
ill
condit
also
suggest
prevent
measur
avoid
gastric
aspir
elev
decubitu
intermitt
check
residu
gastric
content
diet
infus
avoid
ventil
associ
pneumonia
wash
hand
elev
decubitu
special
endotrach
tube
implement
resolut
pulmonari
edema
central
recov
ali
entail
regress
air
space
inflamm
restor
function
alveolarcapillari
membran
accordingli
elev
extravascular
lung
water
measur
use
techniqu
earli
cours
aliard
particularli
index
predict
bodi
weight
associ
poor
prognosi
studi
analyz
evolut
ard
patient
show
unknownsit
infect
adjust
hazard
ratio
hr
ci
multipl
site
infect
adjust
hr
ci
associ
increas
mortal
ard
patient
consider
signific
evalu
sourc
infect
well
organ
system
affect
sepsi
syndrom
order
map
organ
number
nonpulmonari
organ
failur
calcul
prognost
indic
acut
physiolog
chronic
health
evalu
apach
simplifi
acut
physiolog
score
sap
plan
multiorgan
system
approach
treat
diseas
higher
number
multipl
organ
failur
associ
ard
higher
hospit
mortal
trauma
patient
ard
associ
lower
mortal
oliguricren
failur
septic
shock
patient
associ
highest
hospit
mortal
rate
suggest
first
day
hospit
ard
patient
stratifi
treat
accord
sever
syndrom
associ
comorbid
case
seri
patient
earli
sever
ard
mean
apach
ii
score
predict
mortal
median
sofa
score
day
median
nonpulmonari
organ
failur
sepsi
present
patient
septic
shock
vasopressor
use
patient
continu
renal
replac
therapi
use
patient
apach
ii
day
sofa
score
associ
hospit
mortal
day
sofa
score
figur
show
revalu
ard
patient
especi
one
multipl
organ
failur
mainten
sofa
score
higher
day
consid
order
evalu
hidden
sourc
infect
chang
antibiot
accord
day
collect
cultur
moderatesever
ard
patient
pao
fio
phase
iv
random
control
trial
compar
cisatracurium
placebo
hour
show
improv
critic
care
research
practic
adjust
surviv
rate
increas
ventilatorfre
cisatracurium
group
without
signific
increas
muscl
weak
shortterm
paralysi
may
facilit
patientventil
synchroni
set
lung
protect
ventil
shortterm
paralysi
would
elimin
patient
trigger
expiratori
muscl
activ
combin
effect
may
serv
limit
region
overdistent
cyclic
alveolar
collaps
paralysi
may
also
act
lower
metabol
overal
ventilatori
demand
inhal
nitric
oxid
endogen
vasodil
reduc
vq
mismatch
improv
oxygen
pulmonari
vasodil
alveolar
unit
ventil
reduc
pulmonari
vascular
resist
patient
ard
cochran
review
clinic
trial
patient
show
transient
improv
oxygen
benefit
regard
length
icu
hospit
stay
ventilatorfre
day
surviv
increas
renal
impair
observ
inhal
nitric
oxidetr
group
effect
steroid
latestag
fibrot
phase
ard
day
onset
test
phase
iii
studi
ard
network
studi
show
mortal
benefit
treatment
group
higher
mortal
patient
treat
day
onset
recent
seam
colleagu
test
effect
methylprednisolon
infus
earli
ard
patient
compar
placebo
observ
methylprednisolon
therapi
associ
greater
improv
lung
injuri
score
p
shorter
durat
mechan
ventil
p
lower
intens
care
unit
mortal
p
control
subject
day
methylprednisolon
decreas
increas
proteinc
level
p
compar
control
subject
avail
evid
lowdos
steroid
mgkgmethylprednisolon
may
consid
patient
sever
earli
ard
nevertheless
recommend
initi
corticosteroid
beyond
day
onset
ard
ketoconazol
lisofyllin
sivelestat
nacetylcystein
exogen
surfact
recommend
treatment
ard
patient
cumul
posit
fluid
balanc
associ
wors
clinic
outcom
patient
ard
phase
iii
studi
conduct
ard
network
factt
studi
compar
liber
versu
conserv
fluid
strategi
patient
acut
lung
injuri
observ
improv
oxygen
lung
injuri
score
li
shorten
durat
mechan
ventil
without
increas
organ
failur
conserv
group
despit
differ
hospit
mortal
betaagonist
investig
multicent
prospect
random
trial
aerosol
present
alta
studi
intraven
present
studi
studi
show
mortal
benefit
betaagonist
recommend
part
therapi
patient
ard
omega
studi
random
doubleblind
placebocontrol
multicent
trial
analyz
patient
earli
acut
lung
injuri
alloc
receiv
either
twicedaili
enter
supplement
fatti
acid
acid
antioxid
compar
isocalor
control
enter
nutrit
direct
protocol
deliv
separ
studi
supplement
patient
receiv
enter
supplement
fewer
ventilatorfre
day
versu
p
day
diarrhea
versu
p
differ
adjust
mortal
versu
p
recent
random
openlabel
multicent
trial
eden
studi
report
patient
acut
lung
injuri
random
receiv
either
trophic
full
enter
feed
first
day
initi
trophic
enter
feed
improv
ventilatorfre
day
mortal
infect
complic
associ
less
gastrointestin
intoler
final
base
relev
literatur
articl
author
clinic
experi
suggest
goalori
manag
critic
ill
patient
ard
help
improv
clinician
abil
care
patient
shown
patient
ard
correct
ard
diagnosi
acut
onset
increas
respiratori
rate
puls
oximet
desatur
hypoxemia
pao
fio
possibl
get
comput
tomographi
improv
diagnosi
accuraci
permit
differenti
diagnos
help
set
recruit
maneuv
adequ
peep
level
ii
lung
ultrasound
fdgpet
ct
electr
imped
tomographi
pressurevolum
p
v
curv
help
assess
correct
diagnosi
set
protect
mechan
ventil
iii
get
nasal
swab
inferior
respiratori
tract
secret
infect
diagnosi
bal
infect
diagnosi
proinflammatori
mediat
procollagen
iii
measur
iv
get
hemocultur
blood
infect
detect
start
resuscit
measur
septic
shock
start
appropri
antibiot
critic
care
research
practic
v
assess
prognost
indic
apach
sap
sequenti
organ
failur
assess
sofa
score
standard
initi
mechan
ventil
blood
ga
measur
tidal
volum
mlkg
predict
bodi
weight
peep
cmh
rr
classifi
ard
sever
mild
pao
fio
moder
pao
fio
sever
pao
fio
possibl
get
doppler
echocardiogram
assess
left
ventricular
function
right
ventricular
function
systol
pulmonari
arteri
pressur
vena
cava
compress
ii
measur
extravascular
lung
water
avail
case
sever
ard
consid
recruit
maneuv
adequ
peep
titrat
b
case
sever
ard
right
ventricular
dysfunct
pulmonari
arteri
hypertens
consid
prone
posit
inhal
nitric
oxid
c
case
excess
co
retent
paco
mmhg
ph
consid
intratrach
ga
insuffl
extracorpor
co
remov
earli
recognit
ard
modifi
risk
factor
avoid
aggrav
factor
hospit
stay
high
tidal
volum
ventil
multipl
blood
product
transfus
excess
fluid
administr
ventil
associ
pneumonia
gastric
aspir
prevent
could
help
decreas
incid
ii
earli
extens
clinic
laboratori
imag
evalu
risk
patient
allow
correct
diagnosi
ard
assess
comorbid
calcul
prognost
indic
apach
sap
sofa
stratif
sever
ard
plan
care
treatment
iii
rapid
administr
antibiot
resuscit
measur
case
sepsi
septic
shock
associ
protect
ventilatori
strategi
earli
shortterm
paralysi
associ
differenti
ventilatori
techniqu
recruit
maneuv
adequ
peep
titrat
prone
posit
new
ecmo
techniqu
sever
ard
help
improv
prognosi
iv
revalu
ard
patient
third
day
evolut
sofa
biomark
respons
infect
therapi
allow
chang
initi
treatment
plan
help
decreas
ard
mortal
v
fibroprolif
chang
highresolut
ct
ard
predict
mortal
ventil
depend
